Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 05, 2018 16:00 ET | Source: REVA Medical Inc

REVA Medical Reports Third Quarter 2018 Financial Results

SAN DIEGO, Nov. 05, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular medical applications, today provided...
October 31, 2018 19:19 ET | Source: REVA Medical Inc

REVA Announces Commercial Launch of the Fantom Encore Bioresorbable Scaffold

First Fantom Encore Implanted in the FANTOM Post Market Trial SAN DIEGO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer...
October 29, 2018 19:20 ET | Source: REVA Medical Inc

REVA to Hold Third Quarter 2018 Financial Results Call

SAN DIEGO, Oct. 29, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”) has scheduled a conference call to review its third quarter 2018 financial results and provide a...
September 22, 2018 22:42 ET | Source: REVA Medical Inc

REVA Medical Presents Key Data Sets at the Transcatheter Cardiovascular Therapeutics Conference 2018

SAN DIEGO, Sept. 22, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, presented four key...
August 16, 2018 00:05 ET | Source: REVA Medical Inc

New Data for Fantom in Heart Attack Patients to be Presented at the TCT 2018 Conference

SAN DIEGO, Aug. 15, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, will present new data...
August 07, 2018 09:00 ET | Source: REVA Medical Inc

REVA Medical Reports Second Quarter 2018 Financial Results

SAN DIEGO, Aug. 07, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular medical applications, today provided...
July 31, 2018 19:04 ET | Source: REVA Medical Inc

REVA to Hold Second Quarter 2018 Financial Results Call

SAN DIEGO, July 31, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”) has scheduled a conference call to review its second quarter 2018 financial results and provide a...
July 26, 2018 12:24 ET | Source: REVA Medical Inc

UPDATE: REVA Enters Peripheral Artery Disease Space With First-Ever CE Mark of a Bioresorbable Scaffold for Below the Knee Therapy

SAN DIEGO, July 26, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, today announced that...
July 25, 2018 19:15 ET | Source: REVA Medical Inc

REVA Enters Peripheral Artery Disease Space With First-Ever CE Mark of a Bioresorbale Scaffold for Below the Knee Therapy

SAN DIEGO, July 25, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, today announced that...
July 15, 2018 18:59 ET | Source: REVA Medical Inc

Reva Expands Commercial Access to Fantom With New Distribution Partnership in Italy

SAN DIEGO, July 15, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, is expanding commercial...